Mankind Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma Limited has submitted a certificate to the stock exchanges as required under the SEBI (Depositories and Participants) Regulations, 2018. This is a routine regulatory compliance filing, typically submitted by listed companies to confirm details related to their equity shares held in dematerialized (electronic) form with depositories such as NSDL and CDSL. The certificate is usually issued by the company's Registrar and Share Transfer Agent (RTA) and includes data on the total number of shares, the shares held in demat form, and those in physical form.
This is a procedural compliance filing with no direct material impact on the company's business operations, financials, or share price. Shareholders do not need to take any action, and the announcement is purely informational in nature.